Alnylam Pharmaceuticals Inc banner

Alnylam Pharmaceuticals Inc
NASDAQ:ALNY

Watchlist Manager
Alnylam Pharmaceuticals Inc Logo
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Watchlist
Price: 331.16 USD -0.02% Market Closed
Market Cap: $43.7B

Wall Street
Price Targets

ALNY Price Targets Summary
Alnylam Pharmaceuticals Inc

Wall Street analysts forecast ALNY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALNY is 462.14 USD with a low forecast of 238.36 USD and a high forecast of 594.3 USD.

Lowest
Price Target
238.36 USD
28% Downside
Average
Price Target
462.14 USD
40% Upside
Highest
Price Target
594.3 USD
79% Upside
Alnylam Pharmaceuticals Inc Competitors:
Price Targets
PWP
Perella Weinberg Partners
41% Upside
LGI
Lgi Ltd
36% Upside
PRDO
Perdoceo Education Corp
28% Upside

Revenue
Forecast

31% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
31% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 14 years the compound annual growth rate for Alnylam Pharmaceuticals Inc's revenue is 31%. The projected CAGR for the next 3 years is 32%.

Operating Income
Forecast

N/A
Past Growth
69% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
69% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

The compound annual growth rate of Alnylam Pharmaceuticals Inc's operating income for the next 3 years is 69%.

Net Income
Forecast

N/A
Past Growth
109% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss
N/A
Past Growth
109% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss

The compound annual growth rate of Alnylam Pharmaceuticals Inc's net income for the next 3 years is 109%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALNY's stock price target?
Price Target
462.14 USD

According to Wall Street analysts, the average 1-year price target for ALNY is 462.14 USD with a low forecast of 238.36 USD and a high forecast of 594.3 USD.

What is Alnylam Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
32%

For the last 14 years the compound annual growth rate for Alnylam Pharmaceuticals Inc's revenue is 31%. The projected CAGR for the next 3 years is 32%.

What is Alnylam Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
69%

The compound annual growth rate of Alnylam Pharmaceuticals Inc's operating income for the next 3 years is 69%.

What is Alnylam Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
109%

The compound annual growth rate of Alnylam Pharmaceuticals Inc's net income for the next 3 years is 109%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett